AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie cash Flow Statement — Operating cash flow ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Cash Flows (DB)
Latest, FY2025
19,030
Period ended Dec 31, 2025
Change on a year earlier
+1.2%
18,806 in FY2024
History
15 years
Since FY2011
Sources
13
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash Flow Statement — Operating cash flow ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 19,030 | +1.2% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 18,806 | -17.7% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 22,839 | -8.4% | Form 10-K (filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 24,943 | +9.5% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 22,777 | +29.5% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 17,588 | +32.0% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 13,324 | -0.8% | Form 10-K (filed 2020-02-21) ↗ |
| FY2018 | Dec 31, 2018 | 13,427 | +34.8% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 9,960 | +41.5% | Form 10-K (filed 2018-02-16) ↗ |
| FY2016 | Dec 31, 2016 | 7,041 | -6.6% | Form 10-K (filed 2017-02-17) ↗ |
| FY2015 | Dec 31, 2015 | 7,535 | +112.3% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 3,549 | -43.4% | Form 10-K (filed 2015-02-20) ↗ |
| FY2013 | Dec 31, 2013 | 6,267 | -1.2% | Form 10-K (filed 2014-02-21) ↗ |
| FY2012 | Dec 31, 2012 | 6,345 | +1.6% | Form 10-K (filed 2014-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 6,247 | – | Form 10-K (filed 2014-02-21) ↗ |
Breakdown
What makes up cash flow statement — operating cash flow ($m)
Cite this data
StockData. (2026). AbbVie Cash Flow Statement — Operating cash flow ($M) ($M), annual FY2011–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_cash_flow
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.